NetraMark appoints veteran pharmaceutical executive Dr. Keith Fournier to board
NetraMark Holdings Inc. appointed Dr. Keith Fournier, a veteran pharmaceutical executive, to its board of directors. The company cites more than 20 years of global drug development, regulatory strategy, and portfolio leadership experience.
Pharmaceutical industry leader brings more than 20 years of global drug development, regulatory strategy and portfolio leadership experience across AbbVie, Merck KGaA, AstraZeneca and AbivaxTORONTO, Sept.
01, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") TSX:AIAI O…